AirSculpt Technologies, Inc.
NASDAQCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Yogi Jashnani
- Full Time Employees
- 347
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 1111 Lincoln Road Miami Beach FL United States of America 33139
- IPO Date
- Oct 29, 2021
- CIK
- 0001870940
- Website
- airsculpt.com
- Similar Companies
- Business
- AirSculpt Technologies, Inc. (Nasdaq: AIRS) is a provider of minimally invasive body contouring procedures through its branded centers operating under Elite Body Sculpture; the company offers its proprietary AirSculpt technology for precise fat removal and skin tightening across targeted areas including the stomach, back, buttocks, arms, thighs, and chin; fat transfer services to enhance breasts, buttocks, hips, or hands using the patient's own cells; specialized procedures such as Power BBL (Brazilian butt lift), Up a Cup (breast enhancement), Hip Flip (hourglass contouring), AirSculpt+, AirSculpt Smooth for cellulite reduction, and new skin tightening pilots addressing post-GLP-1 medication skin laxity via helium plasma and radiofrequency. Founded in 2012 and headquartered in Miami Beach, Florida, AirSculpt operates over 30 centers primarily in the United States with additional locations in Canada and the United Kingdom, delivering premium services to affluent consumers seeking outpatient aesthetic enhancements without general anesthesia or opioids. Recent developments include the launch of skin tightening pilots in select centers during 2025 to capitalize on GLP-1 demand, expansion of financing options and IT upgrades to boost consultations and conversions, relocation and growth of facilities such as in Atlanta and Scottsdale to meet market needs, a follow-on public stock offering in June 2025 raising funds to retire $16 million in debt, appointment of Mike Doyle as Non-Executive Chairman in November 2025 bringing multi-center healthcare expertise, and the resignation of founder Dr. Aaron Rollins as Executive Chairman the prior week amid strategic transformation focused on revenue stabilization, margin discipline, and GLP-1-aligned growth.
AirSculpt Sees Core Stabilization, Targets $100M-Plus GLP-1 Opportunity
AirSculpt Technologies, Inc. (AIRS) Q2 2026 Earnings Call Transcript
AirSculpt Technologies Q2 Earnings Call Highlights
Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday's Pre-Market Session
AirSculpt Technologies Reports Second Quarter Fiscal 2026 Results
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for Second Quarter Fiscal 2026 Results
AIRS Medical Welcomes Strategic Growth Investment from TA Associates to Accelerate Global Growth in AI-Powered MRI Solutions
Is Prisma AIRS Becoming Palo Alto Networks' Fastest Growth Engine?
AirSculpt Technologies Announces Participation in Upcoming Investor Conferences
AirSculpt Technologies Sees Sales Rebound, GLP-1 Tailwind for Body Contouring Growth
AirSculpt Technologies, Inc. (AIRS) Shareholder/Analyst Call Prepared Remarks Transcript
AirSculpt Technologies Q1 Earnings Call Highlights
AirSculpt Technologies, Inc. (AIRS) Q1 2026 Earnings Call Transcript
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
AirSculpt Technologies Reports First Quarter Fiscal 2026 Results
AirSculpt Technologies Announces Earnings Release Date, Conference Call, and Webcast for First Quarter Fiscal 2026 Results
CORRECTION -- AirSculpt Technologies Reports Fourth Quarter and Full Year Fiscal 2025 Results
Critical Contrast: AirSculpt Technologies (NASDAQ:AIRS) & Bit Digital (NASDAQ:BTBT)
AirSculpt Technologies Q4 Earnings Call Highlights
AirSculpt Technologies, Inc. (AIRS) Q4 2025 Earnings Call Transcript